AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed.Tuesday started off well for AngioDynamics (ANGO -10.18%), maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral vascular disease. In the morning, AngioDynamics reported stronger-than-expected Q4 2025 sales and earnings, with sales of $80.2 million and an adjusted loss of $0.03 per share (instead of the $0.12-per-share forecast).By the end of the day, howe ...

AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday posted a fourth-quarter 2025 adjusted loss of 3 cents per share, compared to the consensus for a per-share loss of 12 cents.Vascular system-focused medical device maker reported sales of $80.2 million, up 12.7% year over year, beating the consensus of $74.26 million.The report also revealed:Med Tech net sales were $35.8 million, a 22% increase from $29.3 million in the prior-year period.Growth was driven by Auryon sales during the quarter of $15.6 million, which ...

AngioDynamics (ANGO) Q4 2025 Earnings Call July 15, 2025 08:00 AM ET Speaker0Morning, and welcome to the AngioDynamics Fiscal Year twenty twenty five Fourth Quarter Earnings Call. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference call is being recorded. The news release detailing AngioDynamics' fiscal twenty twenty five fourth quarter and full year results crossed the wire earlier this morning and is avai ...

AngioDynamics Fourth Quarter and Full Year Earnings Presentation July 15, 2025 Forward-Looking Statements Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics' expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, ...

For Immediate ReleaseChicago, IL – June 9, 2025 – Today, Zacks Equity Research discusses Penumbra (PEN) , Integer Holdings (ITGR) and AngioDynamics (ANGO) .Industry: Medical InstrumentsLink: https://www.zacks.com/commentary/2487141/3-medical-instruments-stocks-winning-big-with-genai-amid-global-gloomOver the past year, advancements in artificial intelligence (AI) and predictive analytics have rapidly revolutionized the Medical Instruments industry, driving innovation in diagnostics, patient monitoring and p ...